What is ZTS's market cap?

$36.86B, based on the Nov 4 close of $89.20.

What is ZTS's P/E ratio?

14.1× trailing-twelve-month earnings of $2.62B.

Does ZOETIS pay a dividend?

Yes. The latest regular dividend was $0.53 per share (ex-date Oct 30), an annualised yield of 2.38%.

How much of ZTS is sold short?

17.5M shares, 4.2% of float, as of Oct 15, 2026.

What sector is ZTS in?

Healthcare, in the Pharmaceuticals industry.

NYSE · ZTSHealthcarePharmaceuticals

ZOETIS INC. (ZTS)

$89.20+7.48%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$89.20▼ 28.33% in range

Nov 4, 2025Low $69.10 · High $131.10Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

ZOETIS closed at $89.20 on Nov 4, up 7.48%, 38.2% below its 52-week closing high. Volume of 9.2M shares was 2.37× its 20-day average (well above normal).

Split-adjusted performance: +25.1% over one month, -19.8% over six months, -38.2% over one year.

In the quarter ended Jun 30, 2026, revenue was $2.47B, down 0.2% from a year earlier, with a net margin of 28.0%.

Short interest was 17.5M shares at the Oct 15 settlement, down 4.9% from the prior report (4.2% of float, 4.1 days to cover).

Market cap$36.86B413.2M shares

Revenue · quarter$2.47B−0.2% YoY

Diluted EPS$1.65+1.2% YoY

P/E · TTM14.1×P/S 3.9×

Net margin28.0%Gross 72.7%

Dividend yield2.38%$0.53 last paid

52-week range69.10 – 144.35−38.2% from high

Volume9.2M2.37× 20-day avg

Volatility · 60d32.1%Annualised

Short % of float4.2%4.1 days to cover

Net cash-$7.37BCash $1.68B

Next earnings—Not scheduled

Split-adjusted performance

1W +14.7%1M +25.1%3M +15.4%6M −19.8%YTD −29.1%1Y −38.2%3Y −43.2%5Y −57.4%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum57

Revenue growth41

Net margin89

Value (low P/E)60

Size98

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →

Shares short17.5M−4.9% vs prior

Days to cover4.1Settled Oct 15

% of float4.2%

Short vol. 10d41.1%of daily volume

Closest peers by size in Pharmaceuticals

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
ZTSZOETIS	$89.20	+7.48%	−19.8%	−0.2%	28.0%	14.1	$36.86B
RPRXRoyalty Pharma	$67.56	+1.75%	+33.2%	+16.5%	2.7%	36.9	$30.08B	Compare
TEVATeva Pharmaceutical Industries Limited	$41.85	−0.14%	+15.2%	−0.8%	−13.9%	69.0	$48.81B	Compare
ROIVRoivant Sciences	$38.23	+6.08%	+32.7%	−33.5%	−13164.8%	—	$27.61B	Compare
UTHRUnited Therapeutics	$608.49	+1.19%	+2.0%	−1.9%	42.5%	19.9	$26.10B	Compare
INSMInsmed	$110.00	+5.32%	−19.8%	+268.4%	−19.1%	—	$24.13B	Compare
VTRSViatris	$19.22	+1.59%	+20.5%	+4.9%	−3.2%	—	$22.08B	Compare
ALNYAlnylam Pharmaceuticals	$161.08	+0.74%	−46.8%	+16.7%	148.6%	7.9	$21.57B	Compare
JAZZJazz Pharmaceuticals	$234.66	+2.14%	+2.7%	+10.4%	−38.9%	74.0	$15.23B	Compare

News about ZOETIS

All news →

Zoetis (ZTS) Ascends While Market Falls: Some Facts to NoteZacks Investment Research · 6d agoNeutral Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to NoteZacks Investment Research · Oct 23, 2026▼ Negative ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?Zacks Investment Research · Oct 21, 2026Neutral Zoetis (ZTS) Outpaces Stock Market Gains: What You Should KnowZacks Investment Research · Oct 9, 2026▼ Negative Vietnam Veterinary Vaccine Import Market and Top 10 Importers Guide 2023-2026 | Import Reliance and Aquaculture Growth Create Market Entry OpportunitiesGlobeNewswire Inc. · Oct 2, 2026▲ Positive

Quick answers

What does ZOETIS do?: Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products.
What is ZTS's market cap?: $36.86B, based on the Nov 4 close of $89.20.
What is ZTS's P/E ratio?: 14.1× trailing-twelve-month earnings of $2.62B.
Does ZOETIS pay a dividend?: Yes. The latest regular dividend was $0.53 per share (ex-date Oct 30), an annualised yield of 2.38%.
How much of ZTS is sold short?: 17.5M shares, 4.2% of float, as of Oct 15, 2026.
What sector is ZTS in?: Healthcare, in the Pharmaceuticals industry.

About ZOETIS

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

HQ: Parsippany, NJ14,500 employeesListed Feb 1, 2013zoetis.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology